The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy

Platelets. 2011;22(5):396-7. doi: 10.3109/09537104.2011.553970. Epub 2011 Mar 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood*
  • Blood Platelets / chemistry
  • Blood Platelets / cytology
  • Blood Platelets / metabolism*
  • Cytokines / analysis
  • Cytokines / biosynthesis
  • Disseminated Intravascular Coagulation / blood*
  • Disseminated Intravascular Coagulation / complications
  • Disseminated Intravascular Coagulation / drug therapy
  • Disseminated Intravascular Coagulation / immunology
  • Disseminated Intravascular Coagulation / pathology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • HMGB1 Protein / analysis*
  • HMGB1 Protein / metabolism
  • Hematologic Neoplasms / blood*
  • Hematologic Neoplasms / complications
  • Hematologic Neoplasms / drug therapy
  • Hematologic Neoplasms / immunology
  • Hematologic Neoplasms / pathology
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Platelet Activation
  • Platelet Count
  • Thrombomodulin / administration & dosage
  • Thrombomodulin / therapeutic use*
  • Treatment Outcome

Substances

  • Biomarkers
  • Cytokines
  • HMGB1 Protein
  • Thrombomodulin